Apg Asset Management N.V. Astrazeneca PLC Transaction History

Apg Asset Management N.V.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$64.85 - $71.7 $5.51 Million - $6.09 Million	-85,000 Reduced 22.78%	288,100 $19.5 Million
Q2 2023 Aug 14, 2023	BUY	$69.91 - $75.81 $4.99 Million - $5.41 Million	71,400 Added 23.67%	373,100 $26.7 Million
Q1 2023 May 12, 2023	BUY	$63.15 - $71.6 $694,650 - $787,599	11,000 Added 3.78%	301,700 $20.9 Million
Q4 2022 Feb 14, 2023	BUY	$54.21 - $70.44 $15.8 Million - $20.5 Million	290,700 New	290,700 $19.7 Million
Q2 2022 Aug 12, 2022	SELL	$59.26 - $71.14 $5.16 Million - $6.2 Million	-87,137 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$55.72 - $67.12 $4.86 Million - $5.85 Million	87,137 New	87,137 $5.2 Million

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Apg Asset Management N.V., based on Form 13F filings with the SEC.

Stay updated on Apg Asset Management N.V. with notifications on news.